These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 6246142

  • 1. Plasma glycoprotein hormone alpha-subunit in the syndrome of gonadal dysgenesis: the effect of estrogen replacement in hypergonadotropic hypogonadism.
    Styne DM, Conte FA, Grumbach MM, Kaplan SL.
    J Clin Endocrinol Metab; 1980 Jun; 50(6):1049-52. PubMed ID: 6246142
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Comparison of hormonal levels of LH and FSH with cytogenetic findings in patients with gonadal dysgenesis].
    Santavý J, Fingerová H, Knopová V, Fargasová I, Zenísek L.
    Bratisl Lek Listy; 1985 May; 83(5):485-92. PubMed ID: 3928097
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Further evidence for differential regulation of follicle-stimulating hormone (FSH) and luteinizing hormone (LH): increased FSH and decreased LH levels in a patient with familial pure gonadal dysgenesis.
    Popovic V, Micic D, Damjanovic S, Calovic L, Rolovic Z, Mijovic A, Petakov M, Manojlovic D, Micic J.
    Postgrad Med J; 1992 Nov; 68(805):925-7. PubMed ID: 1494516
    [Abstract] [Full Text] [Related]

  • 10. Hypogonadism in a male with an immunologically active, biologically inactive luteinizing hormone: characterization of the abnormal hormone.
    Beitins IZ, Axelrod L, Ostrea T, Little R, Badger TM.
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1143-9. PubMed ID: 6785294
    [No Abstract] [Full Text] [Related]

  • 11. Twenty-four-hour luteinizing hormone and follicle-stimulating hormone secretory patterns in gonadal dysgenesis.
    Boyar RM, Finkelstein JW, Roffwarg H, Kapen S, Weitzman D, Hellman L.
    J Clin Endocrinol Metab; 1973 Oct; 37(4):521-5. PubMed ID: 4742536
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Gonadotropin dynamics in patients with gonadal dysgenesis: a model for the study of gonadotropin regulation.
    Yen SS, Tsai CC, Vandenberg G, Rebar R.
    J Clin Endocrinol Metab; 1972 Dec; 35(6):897-904. PubMed ID: 4634488
    [No Abstract] [Full Text] [Related]

  • 19. Radioimmunoassayable plasma luteinizing hormone in primary amenorrhea.
    Reschini E, Giustina G, D'Alberton A, Chierichetti G.
    Am J Obstet Gynecol; 1971 Sep 15; 111(2):173-7. PubMed ID: 5098587
    [Abstract] [Full Text] [Related]

  • 20. Case of ovarian dysgenesis and dilated cardiomyopathy supports existence of Malouf syndrome.
    Narahara K, Kamada M, Takahashi Y, Tsuji K, Yokoyama Y, Ninomiya S, Seino Y.
    Am J Med Genet; 1992 Oct 01; 44(3):369-73. PubMed ID: 1488988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.